ibrutinib
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
16 FDA-registered drug labelers
Aarti Pharmalabs Limited
AbbVie Inc.
Assia Chemical Industries Ltd. - Teva Tech Site
Catalent Micron Technologies, Inc.
Catalent Pharma Solutions, LLC
Dr. Reddy's Laboratories Limited
Hetero Labs Limited
Lonza Guangzhou Pharmaceutical Ltd.
MSN Laboratories Private Limited
Natco Pharma Limited
Pharmacyclics LLC
ScinoPharm Taiwan Ltd.
Shanghai Huilun Jiangsu Pharmaceutical Co., Ltd.
SHILPA PHARMA LIFESCIENCES LIMITED
SUN PHARMACEUTICAL INDUSTRIES, INC.
Wavelength Enterprises LTD
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Imbruvica
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS936563-96-1
PubChem CID24821094
DTXSIDDTXSID60893450
FormulaC25H24N6O2
Mol. Weight440.5 g/mol
SMILESC=CC(=O)N1CCCC(C1)N2C3=NC=NC(=C3C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)N
Data Sources
248210942026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/ibrutinib/cids/JSON
Archive: data/sources/pubchem_name/ibrutinib.json
CAS 936563-96-12026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json